Frontiers in Immunology | Multiple Sclerosis and Neuroimmunology

Original Research

Published on 20 Nov 2024

The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI

in Multiple Sclerosis and Neuroimmunology

Rida Rehman
Albrecht Froehlich
Florian olde Heuvel
Lobna Elsayed
Tobias Boeckers
Markus Huber-Lang
Cristina Morganti-Kossmann
Francesco Roselli

Frontiers in Immunology

doi 10.3389/fimmu.2024.1443940

1,619 views

Original Research

Published on 19 Nov 2024

Stimulation of microneedles alleviates pathology of Parkinson’s disease in mice by regulating the CD4+/CD8+ cells from the periphery to the brain

in Multiple Sclerosis and Neuroimmunology

Jin Hee Kim
Yujin Choi
Jin Se Kim
Hanbyeol Lee
In Gyoung Ju
Na Young Yoo
Sookie La
Do Hyeon Jeong
Changsu Na
Hi-Joon Park

Frontiers in Immunology

doi 10.3389/fimmu.2024.1454102

1,796 views

Case Report

Published on 18 Nov 2024

Telitacicept in combination with B-cell depletion therapy in MuSK antibody-positive myasthenia gravis: a case report and literature review

in Multiple Sclerosis and Neuroimmunology

Jia Wang
Haotao Zheng
Jia Wei
Jiaping Wu
Ziyang Feng
Xueqin Chen
Yangsicheng Liu
Wenxin Qin
Xiude Qin
Fanxin Kong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1456822

1,799 views
2 citations

Original Research

Published on 14 Nov 2024

Global perspectives on the contribution of B cells to multiple sclerosis: an in-depth examination and evaluation

in Multiple Sclerosis and Neuroimmunology

Xinzhan Jiang
Hongyu Zhang
Yongtao Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1442694

1,852 views
1 citation

Original Research

Published on 12 Nov 2024

Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Fernando Rodríguez-Jorge
José Ignacio Fernández-Velasco
Noelia Villarrubia
Julia Gracia-Gil
Eva Fernández
Virginia Meca-Lallana
Carolina Díaz-Pérez
Susana Sainz de la Maza
Eva María Pacheco
Ana Quiroga

Frontiers in Immunology

doi 10.3389/fimmu.2024.1480676

2,390 views

Case Report

Published on 07 Nov 2024

Case report: The case report of ofatumumab, a fully human anti-CD20 monoclonal antibody, in the treatment of KLHL11 encephalitis

in Multiple Sclerosis and Neuroimmunology

Min Deng
Fei Zeng
Zhaohong Kong
Tao Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1456840

1,031 views
1 citation

Case Report

Published on 06 Nov 2024

Case report: Infectious mononucleosis with bilateral retinal haemorrhages under myelin oligodendrocyte glycoprotein antibody-associated disease

in Multiple Sclerosis and Neuroimmunology

Yuyu Li
Mingming Sun
Shihui Wei
Quangang Xu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1480134

1,160 views

Editorial

Published on 01 Nov 2024

Editorial: Community series in reassessing the immune system contribution in multiple sclerosis: therapeutic target, biomarkers of disease and immune pathogenesis, volume II

in Multiple Sclerosis and Neuroimmunology

Maria Teresa Cencioni
Luisa Maria Villar
Roberta Magliozzi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1505829

673 views

Original Research

Published on 01 Nov 2024

Effects of early intervention in neuromyelitis optica spectrum disorder patients with seropositive AQP4 antibodies

in Multiple Sclerosis and Neuroimmunology

Binbin Xue
Jia Li
Dewei Xie
Yiyun Weng
Xu Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1458556

1,431 views

General Commentary

Published on 23 Oct 2024

Commentary: Evaluation of the causal effects of immune cells on ischemic stroke: a Mendelian randomization study

in Multiple Sclerosis and Neuroimmunology

Xingcheng Zhu
Junhao Chen
Junxian Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1450086

1,068 views

Case Report

Published on 22 Oct 2024

Elevation of serum neurofilament light-chain levels disclose possible occult progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient receiving ozanimod: a case report

in Multiple Sclerosis and Neuroimmunology

Carlos Quintanilla-Bordás
David Gorriz
Laura Cubas-Núñez
Jéssica Castillo-Villalba
Joan Carreres-Polo
Bonaventura Casanova
Francisco Carlos Pérez-Miralles

Frontiers in Immunology

doi 10.3389/fimmu.2024.1465678

1,548 views
1 citation

Perspective

Published on 22 Oct 2024

The arisal of data spaces: why I am excited and worried

in Multiple Sclerosis and Neuroimmunology

Liesbet M. Peeters

Frontiers in Immunology

doi 10.3389/fimmu.2024.1461361

820 views
1 citation

Brief Research Report

Published on 18 Oct 2024

Multiple sclerosis and COVID-19: a bidirectional Mendelian randomization study

in Multiple Sclerosis and Neuroimmunology

Shitong Liu
Yixin Liang
Binbin Sheng
Rongxin Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1451347

1,799 views

Review

Published on 18 Oct 2024

Big data and artificial intelligence applied to blood and CSF fluid biomarkers in multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Georgina Arrambide
Manuel Comabella
Carmen Tur

Frontiers in Immunology

doi 10.3389/fimmu.2024.1459502

1,998 views
1 citation

Correction

Published on 17 Oct 2024

Corrigendum: Relationship between gut microbiota and multiple sclerosis: a scientometric visual analysis from 2010 to 2023

in Multiple Sclerosis and Neuroimmunology

Qingrong Ouyang
Hao Yu
Lei Xu
Ming Yu
Yunwei Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1489276

546 views

Original Research

Published on 14 Oct 2024

Ischemia-induced endogenous Nrf2/HO-1 axis activation modulates microglial polarization and restrains ischemic brain injury

in Multiple Sclerosis and Neuroimmunology

Ping-Chang Kuo
Wen-Tsan Weng
Barbara A. Scofield
Hallel C. Paraiso
I-Chen Ivorine Yu
Jui-Hung Jimmy Yen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1440592

1,634 views